Surgery MCQ 135

A 45-year-old patient undergoes a routine colonoscopy, during which a small, 0.8 cm lesion is found in the rectum. A biopsy reveals that the lesion is a carcinoid tumor. The patient has no symptoms and no evidence of metastasis. The gastroenterologist discusses the treatment options with the patient.

The treatment of choice for a patient with rectal carcinoids of less than 1 cm in size is:

A. Local excision  
B. Anterior resection  
C. Short-term chemotherapy followed by local excision  
D. Short course of radiotherapy followed by local excision  


The correct answer is A. Local excision.

Explanation:

Local Excision (A):

– Local excision is the treatment of choice for small rectal carcinoids (less than 1 cm) because these tumors are typically low-grade, slow-growing, and have a low risk of metastasis.

– The procedure involves removing the tumor along with a small margin of surrounding healthy tissue.

– This approach is minimally invasive and has a high success rate for tumors of this size.

NEXT


Explanation of Other Options:

Anterior Resection (B): Anterior resection is a more extensive surgery typically reserved for larger tumors or those with high-risk features. It is not necessary for small carcinoids less than 1 cm.

Short-term Chemotherapy followed by Local Excision (C): Chemotherapy is not usually required for small rectal carcinoids as they are generally not aggressive and have a low potential for spread.

Short Course of Radiotherapy followed by Local Excision (D): Radiotherapy is also not typically indicated for small rectal carcinoids due to their low metastatic potential and the effectiveness of local excision alone.

In summary, for rectal carcinoids less than 1 cm in size, local excision is the preferred treatment due to its efficacy and minimal invasiveness, making A. Local excision the correct answer.


Treatment Options for Rectal Carcinoids Based on Tumor Size

Rectal Carcinoids Smaller Than 1 cm (Slightly Less Than Half an Inch)

Small rectal carcinoids, typically those smaller than 1 cm, have a low risk of metastasis and can usually be treated effectively with minimally invasive procedures. The recommended treatments include:

Endoscopic Removal: Procedures such as polypectomy or endoscopic submucosal resection are considered sufficient.

Local Excision: This involves the surgical removal of the tumor with a small margin of surrounding tissue.

Rectal Carcinoids Between 1 and 1.9 cm

Tumors within this size range present a more unpredictable behavior, with a metastatic rate varying between 4% and 30%. Treatment options are influenced by the tumor’s characteristics and potential risk factors:

Rectal Resection: For tumors between 1.0 to 1.9 cm, especially those with high-risk features, rectal resection may be necessary. This involves the surgical removal of part of the rectum where the tumor is located.

Rectal Carcinoids Larger Than 2 cm

Larger rectal carcinoids, particularly those over 2 cm, pose a higher risk and often require more extensive surgical interventions due to their potential to invade deeper layers of the rectal wall and metastasize:

Extensive Surgery: Surgical options similar to those used for adenocarcinomas are recommended, including:

  – Low Anterior Resection: Removal of the affected portion of the rectum.

  – Abdominoperineal Resection with Colostomy: More extensive surgery involving the removal of the rectum and anus, resulting in a colostomy.

General Approach

For rectal carcinoid tumors larger than 20 mm or those with specific features such as a depression in the tumor center, surgical resection is often advised over endoscopic methods to ensure comprehensive treatment.

Summary

The treatment approach for rectal carcinoids is largely determined by the tumor size:

Smaller Tumors (<1 cm): Generally managed with endoscopic procedures or local excision.

Medium Tumors (1-1.9 cm): May require rectal resection, particularly if high-risk features are present.

Larger Tumors (>2 cm): Typically necessitate more extensive surgery to effectively control the disease and prevent metastasis.

This stratified treatment strategy aims to balance effective disease management with the minimization of procedural invasiveness.